It is a semi-synthetic analogue of erythromycin prepared as means of overcoming acid lability. Our in-depth knowledge and industrial expertise has enabled us to emerge as a reputed organization engaged in offering Erythromycin Oxime. It inhibits bacterial protein synthesis by binding to bacterial 50S ribosomal subunits. The drug inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erythromycin Oxime is used in the treatment of infections caused by susceptible strains of microorganisms.